Previous 10 |
Merger activity increased last week with eight new deals announced and four pending deals closing. Deal Statistics: New Deals: The acquisition of Rowan Companies (RDC) by Ensco (ESV) for $3.44 billion in an all stock deal. Under the terms of the transaction agreement, Rowan sh...
BERWYN, Pa. , Oct. 15, 2018 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Corium International, Inc. ("Corium" or the "Company") (NASDAQ: CORI) concerning possible breaches of fiduciary duty and other violations of law related to t...
NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Corium International was up nearly 53% in Friday’s trading session on news that it has agreed to sell itself. Shares of Verastem were down almost 10% on news that it is selling $150 million worth of convertible notes. RDI Initiates Cove...
NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Corium International, Inc. (NASDAQ: CORI) on behalf of stockholders concerning the proposed acquisition of the company by Gurnet Point Capital. ...
Thinly traded Corium International ( CORI +50.7% ) is up on a whopping 83x surge in volume following its announcement that Gurnet Point Capital will acquire its outstanding shares at $12.50 each. More news on: Corium International, Inc., Healthcare stocks news, Merger & acquisition...
CORI +51% on being acquired by Gurnet Point Capital. More news on: Corium International, Inc., India Globalization Capital, Inc, Tetraphase Pharmaceuticals, Stocks on the move, , Top stock market news, Read more ...
Gurnet Point Capital or GPC agrees to acquire Corium (NASDAQ: CORI ) that develops, manufactures and commercializes specialty trans-dermal products. More news on: Corium International, Inc., Merger & acquisition news, Healthcare stocks news, Read more ...
Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex Donepezil MENLO PARK, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Corium Internat...
The following slide deck was published by Corium International, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Corium International Inc. Company Name:
CORI Stock Symbol:
NASDAQ Market:
MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...